Distinction of clenbuterol intake from drug or contaminated food of animal origin in a controlled administration trial – the potential of enantiomeric separation for doping control analysis

References

• Barbosa J, Cruz C, Martins J, Silva JM, Neves C, Alves C, Ramos F, Da Silveira MI. 2005. Food poisoning by clenbuterol in Portugal. Food Addit Contam. 22:563–566.
   PubMed Web of Science ®Google Scholar
• Brambilla G, Cenci T, Franconi F, Galarini R, Macri A, Rondoni F, Strozzi M, Loizzo A. 2000. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol Lett. 114:47–53.
   PubMed Web of Science ®Google Scholar
• Brambilla G, Loizzo A, Fontana L, Strozzi M, Guarino A, Soprano V. 1997. Food poisoning following consumption of clenbuterol-treated veal in Italy. Jama. 278:635.
   PubMed Web of Science ®Google Scholar
• Brockway JM, MacRae JC, Williams PE. 1987. Side effects of clenbuterol as a repartitioning agent. Vet Rec. 120:381–383.
   PubMed Web of Science ®Google Scholar
• Collins S. 2011. Beta-adrenoceptor signaling networks in adipocytes for recruiting stored fat and energy expenditure. Front Endocrinol (Lausanne). 2:102.
   PubMedGoogle Scholar
• Deutsches Institut für Normung. 1986. Calibration of analytical methods, evaluation of analytical results and linear calibration functions used to determine the performance characteristics of analytical methods. Berlin (Germany): Beuth Verlag GmbH.
   Google Scholar
• Drug Enforcement Administration. 2007. Drugs and chemicals of concern - clenbuterol [website]: US Department of Justice. [cited 2007 Feb 22]. Available from: http://www.deadiversion.usdoj.gov/drugs_concern/clenbuterol.htm
   Google Scholar
• EC. 1996. Council directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of ß-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC.
   Google Scholar
• EEC. 1990. Council regulation (EEC) No 2377/90 of 26 June 1990 laying down a community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin.
   Google Scholar
• Elliott CT, Shortt HD, Kennedy DG, McCaughey WJ. 1996. Monitoring for clenbuterol abuse in N. Ireland 1989–1994. Vet Q. 18:41–44.
   PubMed Web of Science ®Google Scholar
• Gausepohl C, Blaschke G. 1998. Stereoselective determination of clenbuterol in human urine by capillary electrophoresis. J Chromatogr B. 25:443–446.
   Web of Science ®Google Scholar
• Geyer H, Parr MK, Köhler K, Mareck U, Schänzer W, Thevis M. 2008. Nutritional supplements cross-contaminated and faked with doping substances. J Mass Spectrom. 713:892–902.
   Web of Science ®Google Scholar
• Guddat S, Fussholler G, Geyer H, Thomas A, Braun H, Haenelt N, Schwenke A, Klose C, Thevis M, Schanzer W. 2012. Clenbuterol - regional food contamination a possible source for inadvertent doping in sports. Drug Test Anal. 4:534–538.
   PubMed Web of Science ®Google Scholar
• Hemmersbach P, Tomten S, Nilsson S, Oftebro H, Havrevoll O, Oen B, Birkeland K. 1995. Illegal use of anabolic agents in animal fattening - consequences for doping analysis. In: Donike M, Geyer H, Gotzmann A, Mareck-Engelke U, editors. Recent advances in doping analysis (2). Cologne: Sport und Buch Strauß; p. 185–191.
   Google Scholar
• Hirosawa I, Ishikawa M, Ogino M, Ito H, Hirao T, Yamada H, Asahi M, Kotaki H, Sai Y, Miyamoto K. 2014. Enantioselective disposition of clenbuterol in rats. Biopharm Drug Dispos. 35:207–217. Epub 2013/12/11.
   PubMed Web of Science ®Google Scholar
• Kuiper HA, Noordam MY, van Dooren-Flipsen MM, Schilt R, Roos AH. 1998. Illegal use of beta-adrenergic agonists: European community. J Anim Sci. 76:195–207.
   PubMed Web of Science ®Google Scholar
• Maltin CA, Delday MI, Hay SM, Smith FG, Lobley GE, Reeds PJ. 1987. The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle. Biosci Rep. 7:143–149.
   PubMed Web of Science ®Google Scholar
• Martinez-Navarro JF. 1990. Food poisoning related to consumption of illicit beta-agonist in liver. Lancet. 336:1311.
   PubMed Web of Science ®Google Scholar
• Meyer HH. 1991. The illegal practice and resulting risks versus the controlled use of licensed drugs: views on the present situation in Germany. Ann Rech Vet. 22:299–304.
   PubMedGoogle Scholar
• Mitchell GA, Dunnavan G. 1998. Illegal use of beta-adrenergic agonists in the United States. J Anim Sci. 76:208–211.
   PubMed Web of Science ®Google Scholar
• Nicoli R, Petrou M, Badoud F, Dvorak J, Saugy M, Baume N. 2013. Quantification of clenbuterol at trace level in human urine by ultra-high pressure liquid chromatography-tandem mass spectrometry. J Chromatogr A. 1292:142–150.
   PubMed Web of Science ®Google Scholar
• Parr MK, Bokland MH, Liebetrau F, Schmidt AH, Schänzer W, Sterk SS. 2013. Enantiomeric separation of clenbuterol as analytical strategy to distinguish abuse from meat contamination. In: Schänzer W, Geyer H, Gotzmann A, Mareck U, editors. Recent advances in doping analysis (21). Cologne: Sportverlag Strauß; p. 26.
   Google Scholar
• Parr MK, Köhler K, Geyer H, Guddat S, Schänzer W. 2008. Clenbuterol marketed as dietary supplement. Biomed Chromatogr. 22:298–300.
   PubMed Web of Science ®Google Scholar
• Pulce C, Lamaison D, Keck G, Bostvironnois C, Nicolas J, Descotes J. 1991. Collective human food poisonings by clenbuterol residues in veal liver. Vet Hum Toxicol. 33:480–481.
   PubMedGoogle Scholar
• Rehfeldt C, Weikard R, Reichel K. 1994. [The effect of the beta-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats]. Arch Tierernahr. 45:333–344.
   PubMedGoogle Scholar
• Rose MD, Shearer G, Farrington WH. 1995. The effect of cooking on veterinary drug residues in food: 1. Clenbuterol. Food Addit Contam. 12:67–76.
   PubMed Web of Science ®Google Scholar
• Salleras L, Dominguez A, Mata E, Taberner JL, Moro I, Salva P. 1995. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep. 110:338–342.
   PubMed Web of Science ®Google Scholar
• Smith DJ. 1998. Total radioactive residues and clenbuterol residues in edible tissues, and the stereochemical composition of clenbuterol in livers of broilers after exposure to three levels of dietary [14C]clenbuterol HCl and three preslaughter withdrawal periods. J Anim Sci. 76:3043–3053. Epub 1999/02/03.
   PubMed Web of Science ®Google Scholar
• Smith DJ. 2000. Stereochemical composition of clenbuterol residues in edible tissues of swine. J Agric Food Chem. 48:6036–6043.
   PubMed Web of Science ®Google Scholar
• Spiller HA, James KJ, Scholzen S, Borys DJ. 2013. A descriptive study of adverse events from clenbuterol misuse and abuse for weight loss and bodybuilding. Subst Abus. 34:306–312.
   PubMed Web of Science ®Google Scholar
• Sporano V, Grasso L, Esposito M, Oliviero G, Brambilla G, Loizzo A. 1998. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning. Vet Hum Toxicol. 40:141–143.
   PubMedGoogle Scholar
• Sterk S, Parr MK. 2011. Clenbuterol in meat: a source for a positive doping control? Search for analytical strategy to distinguish abuse from meat contamination. World Anti-Doping Agency. Available from: www.wada-ama.org
   Google Scholar
• Thevis M, Geyer L, Geyer H, Guddat S, Dvorak J, Butch A, Sterk SS, Schänzer W. 2013. Adverse analytical findings with clenbuterol among U-17 soccer players attributed to food contamination issues. Drug Test Anal. 5:372–376. Epub 04.04.2013.
   PubMed Web of Science ®Google Scholar
• Thevis M, Schebalkin T, Thomas A, Schänzer W. 2005. Quantification of clenbuterol in human plasma and urine by liquid chromatography-tandem mass spectrometry. Chromatographia. 62:435–439.
   Web of Science ®Google Scholar
• Thevis M, Schrader Y, Thomas A, Sigmund G, Geyer H, Schänzer W. 2008. Analysis of confiscated black market drugs using chromatographic and mass spectrometric approaches. J Anal Toxicol. 32:232–240. Epub 2008/04/10.
   PubMed Web of Science ®Google Scholar
• Thevis M, Thomas A, Beuck S, Butch A, Dvorak J, Schänzer W. 2013. Does the analysis of the enantiomeric composition of clenbuterol in human urine enable the differentiation of illicit clenbuterol administration from food contamination in sports drug testing? Rapid Commun Mass Spectrom. 27:507–512.
   PubMed Web of Science ®Google Scholar
• Waldeck B, Widmark E. 1985. Steric aspects of agonism and antagonism at beta-adrenoceptors - experiments with the enantiomers of clenbuterol. Acta Pharmacol Tox. 56:221–227.
   PubMedGoogle Scholar